Needham, MA (PRWEB) February 22, 2011
Cambridge Healthtech Institute and Bio-IT World is pleased to announce the 11th Annual Structure-Based Drug Design (SBDD) conference to be held on June 8-10, 2011 at the Royal Sonesta Hotel Boston in Cambridge, Massachusetts. This meeting serves as the annual forum for the structure-based drug design community, providing insights on the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.
“Building on the well-established reputation among the SBDD community, this conference is a new attempt to bring to focus the latest informatics tools and high performance computing technology for drug design,” said Ming Guo, conference producer for Cambridge Healthtech Institute. “We are thrilled with the caliber of our speakers, and anticipate a fascinating, interactive and highly educational event.”
This meeting brings together presentations from a preeminent internationally recognized faculty including a keynote presentation by David E. Shaw, Ph.D., who was appointed to the President’s Council of Advisors on Science and Technology by President Clinton in 1994 and once again by President Obama in 2009. Dr. Shaw’s presentation titled “Millisecond-Long Molecular Dynamics Simulations of Proteins on a Special-Purpose Machine” will take place on Friday, June
10.
The main conference agenda features comprehensive presentations and an exhibit/poster hall that will stimulate dialogue on issues that are most relevant to drug design, such as:



